Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr;82(966):280-4.
doi: 10.1136/pmj.2005.039032.

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors

C Daousi  1 , I F Casson, G V Gill, I A MacFarlane, J P H Wilding, J H Pinkney
Affiliations

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors

C Daousi et al. Postgrad Med J. 2006 Apr.

Abstract

Aims: To determine the prevalence of overweight and obesity among patients with type 1 and type 2 diabetes mellitus attending a secondary care diabetes clinic in the United Kingdom, and to assess the impact of overweight and obesity on glycaemic control and cardiovascular risk factors in patients with type 2 diabetes.

Methods: 3637 patients with diabetes were identified from the hospital electronic diabetes register, 916 with type 1 diabetes (mean (SD) age 40.4 (15.1) years, 496 male) and 2721 with type 2 diabetes (mean (SD) age 62.5 (11.8) years, 1436 male). Data on body mass index (BMI), glycaemic control, lipid profiles, and blood pressure were extracted.

Results: Of patients with type 1 diabetes, 55.3% were overweight (BMI >or=25 kg/m(2)), 16.6% were obese (BMI >or=30 kg/m(2)), and 0.4% had morbid obesity (BMI >or=40 kg/m(2)). In contrast, 86% of patients with type 2 diabetes were overweight or obese, 52% were obese, and 8.1% had morbid obesity. Obese patients with type 2 diabetes were younger, had poorer glycaemic control, higher blood pressures, worse lipid profiles, and were more likely to be receiving antihypertensive and lipid lowering drugs compared with patients with BMI <30 kg/m(2).

Conclusions: Obesity is the rule among patients attending this hospital diabetes clinic, with 86% of those with type 2 diabetes overweight or obese. Obesity is associated with significantly worse cardiovascular risk factors in this patient group, suggesting that more active interventions to control weight gain would be appropriate.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared.

References

    1. Pinkney J. Prevention and cure of type 2 diabetes. BMJ 2002325232–233. - PMC - PubMed
    1. Tuomilehto J, Lindstrom J, Eriksson J G.et al Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 20013441343–1350. - PubMed
    1. Knowler W C, Barrett‐Connor E, Fowler S E.et al Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002346393–403. - PMC - PubMed
    1. Pan X R, Li G W, Hu Y H.et al Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 199720537–544. - PubMed
    1. Torgerson J S, Hauptman J, Boldrin M N.et al XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 200427155–161. - PubMed